Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-3.62Interest Coverage
VS
Market
Sector
Industry
History
$ 59.38Close
$ 7.36 - $ 62.99 52-Week Range
Ticker Information
Ticker
NKTRCompany Name
NEKTAR THERAPEUTICSSector
HealthcareIndustry
BiotechnologyExchange
NASDAQNEKTAR THERAPEUTICS - Interest Coverage Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NKTR - Int. Coverage Historical data
| Date | Earning Before Interest & Taxes (EBIT) | Interest Expense | Interest Coverage |
|---|---|---|---|
| 6/30/2025 | $ -96.12M | $ 26.54M | -3.62 |
| 3/31/2025 | $ -105.64M | $ 27.55M | -3.83 |
| 12/31/2024 | $ -91.09M | $ 28.11M | -3.24 |
| 9/30/2024 | $ -143.48M | $ 24.83M | -5.78 |
| 6/30/2024 | $ -152.44M | $ 24.72M | -6.17 |
| 3/31/2024 | $ -151.55M | $ 24.46M | -6.2 |
| 12/31/2023 | $ -250.92M | $ 25.33M | -9.9 |
| 9/30/2023 | $ -265.02M | $ 25.67M | -10.33 |
| 6/30/2023 | $ -277.29M | $ 26.71M | -10.38 |
| 3/31/2023 | $ -384.01M | $ 27.79M | -13.82 |
Key Performance Insights, Last 5 Years
- NEKTAR THERAPEUTICS's latest trailing twelve months (TTM) Int. Coverage stands at -9.56.
- Over the past 5 years, NEKTAR THERAPEUTICS's average Int. Coverage has been -9.21.
- The median Int. Coverage for NEKTAR THERAPEUTICS during this period was -10.04
- NEKTAR THERAPEUTICS reached its highest Int. Coverage over the past 5 years at -3.24.
- The lowest Int. Coverage recorded by NEKTAR THERAPEUTICS in the same timeframe -14.22
NEKTAR THERAPEUTICS's Int. Coverage vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Coverage Benchmarks
Similar metrics to Int. Coverage:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Dividend Coverage - [Calculation] The Dividend Coverage Ratio, or dividend cover, describes how often a business can pay its annual dividend to its shareholders. The dividend coverage ratio is calculated by dividing the company’s Earnings per Share [EPS] by its Dividend per Share [DPS].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
Definition of Interest Coverage
[Calculation] The Interest Coverage Ratio is a debt and profitability ratio that describes how easily a business can pay interest on its outstanding [Debt]. It is calculated by dividing the company’s earnings before interest and taxes [EBIT] by its interest expenses [IntExp].EBIT / Int. Exp.
(=) Int. Coverage Int. Coverage for NEKTAR THERAPEUTICS is calculated as follows: EBIT [ $ -397.2M ] / Int. Exp. [ $ 41.55M ]
(=) Int. Coverage [ -9.56 ] NKTR - Interest Coverage, Last 5 years
-14.22
Minimum
Sep 30, 2022
-3.24
Maximum
Dec 31, 2024
-9.21
Average
-10.04
Median
Int. Coverage Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Coverage for companies in the Total Stock Market. The average Int. Coverage of the companies is 2.15 with a standard deviation of 8.46.
The following table provides additional summary stats:
Int. Coverage in the Market:
| filtered constituents | 2.37K |
|---|---|
| min | -25.49 |
| max | 28.75 |
| average | 2.15 |
| median | 2.08 |
| std | 8.46 |